AstraZeneca
AstraZeneca is seeking an In Vivo Scientist to design, execute, and interpret in vivo studies supporting discovery and early development programs in immunology. The role involves generating translational data, collaborating across pharmacology, immunology, and translational sciences, and contributing to high‑impact portfolios targeting serious immune‑mediated diseases.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
Principal Scientist In vivo Immunology
Sanofi
Scientist I/II
Monte Rosa Therapeutics, Inc
Senior Scientist, In Vitro and In Vivo Pharmacology
Kiniksa Pharmaceuticals
Scientist/Senior Scientist
Flagship Pioneering, Inc.
Associate Scientist / Scientist, Immunology & Pharmacology
PharmaEssentia
Scientist, Immunology & Pharmacology (Hematologic Malignancies)
PharmaEssentia